Search

everythinglearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

New treatments for lupus show promise, but more research is needed, especially for children.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Adalimumab improved folliculitis decalvans in most patients.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Nanoemulgels improve skin disorder treatment by delivering drugs more effectively and reducing application frequency.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.